These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 31822997)

  • 1. Human subiculo-fornico-mamillary system in Alzheimer's disease: Tau seeding by the pillar of the fornix.
    Thierry M; Boluda S; Delatour B; Marty S; Seilhean D; ; Potier MC; Duyckaerts C
    Acta Neuropathol; 2020 Mar; 139(3):443-461. PubMed ID: 31822997
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Controlled cortical impact traumatic brain injury in 3xTg-AD mice causes acute intra-axonal amyloid-β accumulation and independently accelerates the development of tau abnormalities.
    Tran HT; LaFerla FM; Holtzman DM; Brody DL
    J Neurosci; 2011 Jun; 31(26):9513-25. PubMed ID: 21715616
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Aβ-induced acceleration of Alzheimer-related τ-pathology spreading and its association with prion protein.
    Gomes LA; Hipp SA; Rijal Upadhaya A; Balakrishnan K; Ospitalieri S; Koper MJ; Largo-Barrientos P; Uytterhoeven V; Reichwald J; Rabe S; Vandenberghe R; von Arnim CAF; Tousseyn T; Feederle R; Giudici C; Willem M; Staufenbiel M; Thal DR
    Acta Neuropathol; 2019 Dec; 138(6):913-941. PubMed ID: 31414210
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Distinctive temporal profiles of detergent-soluble and -insoluble tau and Aβ species in human Alzheimer's disease.
    Koss DJ; Dubini M; Buchanan H; Hull C; Platt B
    Brain Res; 2018 Nov; 1699():121-134. PubMed ID: 30102892
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anatomic survey of seeding in Alzheimer's disease brains reveals unexpected patterns.
    Stopschinski BE; Del Tredici K; Estill-Terpack SJ; Ghebremedhin E; Yu FF; Braak H; Diamond MI
    Acta Neuropathol Commun; 2021 Oct; 9(1):164. PubMed ID: 34635189
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Soluble Conformers of Aβ and Tau Alter Selective Proteins Governing Axonal Transport.
    Sherman MA; LaCroix M; Amar F; Larson ME; Forster C; Aguzzi A; Bennett DA; Ramsden M; Lesné SE
    J Neurosci; 2016 Sep; 36(37):9647-58. PubMed ID: 27629715
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hippocampal phospho-tau/MAPT neuropathology in the fornix in Alzheimer disease: an immunohistochemical autopsy study.
    Plowey ED; Ziskin JL
    Acta Neuropathol Commun; 2016 Oct; 4(1):114. PubMed ID: 27793193
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tau-amyloid interactions in the rTgTauEC model of early Alzheimer's disease suggest amyloid-induced disruption of axonal projections and exacerbated axonal pathology.
    Pooler AM; Polydoro M; Wegmann SK; Pitstick R; Kay KR; Sanchez L; Carlson GA; Gomez-Isla T; Albers MW; Spires-Jones TL; Hyman BT
    J Comp Neurol; 2013 Dec; 521(18):4236-48. PubMed ID: 23839581
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Soluble pre-fibrillar tau and β-amyloid species emerge in early human Alzheimer's disease and track disease progression and cognitive decline.
    Koss DJ; Jones G; Cranston A; Gardner H; Kanaan NM; Platt B
    Acta Neuropathol; 2016 Dec; 132(6):875-895. PubMed ID: 27770234
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Amyloid-β plaques enhance Alzheimer's brain tau-seeded pathologies by facilitating neuritic plaque tau aggregation.
    He Z; Guo JL; McBride JD; Narasimhan S; Kim H; Changolkar L; Zhang B; Gathagan RJ; Yue C; Dengler C; Stieber A; Nitla M; Coulter DA; Abel T; Brunden KR; Trojanowski JQ; Lee VM
    Nat Med; 2018 Jan; 24(1):29-38. PubMed ID: 29200205
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Amyloid-β pathology enhances pathological fibrillary tau seeding induced by Alzheimer PHF in vivo.
    Vergara C; Houben S; Suain V; Yilmaz Z; De Decker R; Vanden Dries V; Boom A; Mansour S; Leroy K; Ando K; Brion JP
    Acta Neuropathol; 2019 Mar; 137(3):397-412. PubMed ID: 30599077
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tau-proximity ligation assay reveals extensive previously undetected pathology prior to neurofibrillary tangles in preclinical Alzheimer's disease.
    Bengoa-Vergniory N; Velentza-Almpani E; Silva AM; Scott C; Vargas-Caballero M; Sastre M; Wade-Martins R; Alegre-Abarrategui J
    Acta Neuropathol Commun; 2021 Jan; 9(1):18. PubMed ID: 33509301
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Beta-protein/A4 deposits are not associated with hyperphosphorylated tau in somatostatin neurons in the hypothalamus of Alzheimer's disease patients.
    van de Nes JA; Konermann S; Nafe R; Swaab DF
    Acta Neuropathol; 2006 Feb; 111(2):126-38. PubMed ID: 16456666
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pathogenic tau modifications occur in axons before the somatodendritic compartment in mossy fiber and Schaffer collateral pathways.
    Christensen KR; Beach TG; Serrano GE; Kanaan NM
    Acta Neuropathol Commun; 2019 Feb; 7(1):29. PubMed ID: 30819250
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pick's disease: hyperphosphorylated tau protein segregates to the somatoaxonal compartment.
    Probst A; Tolnay M; Langui D; Goedert M; Spillantini MG
    Acta Neuropathol; 1996 Dec; 92(6):588-96. PubMed ID: 8960316
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tau seeding activity begins in the transentorhinal/entorhinal regions and anticipates phospho-tau pathology in Alzheimer's disease and PART.
    Kaufman SK; Del Tredici K; Thomas TL; Braak H; Diamond MI
    Acta Neuropathol; 2018 Jul; 136(1):57-67. PubMed ID: 29752551
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Propagation of Aß pathology: hypotheses, discoveries, and yet unresolved questions from experimental and human brain studies.
    Eisele YS; Duyckaerts C
    Acta Neuropathol; 2016 Jan; 131(1):5-25. PubMed ID: 26715565
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The lesions of Alzheimer's disease: which therapeutic perspectives?].
    Duyckaerts C; Perruchini C; Lebouvier T; Potier MC
    Bull Acad Natl Med; 2008 Feb; 192(2):303-18; discussion 318-21. PubMed ID: 18819685
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reduction of aggregated Tau in neuronal processes but not in the cell bodies after Abeta42 immunisation in Alzheimer's disease.
    Boche D; Donald J; Love S; Harris S; Neal JW; Holmes C; Nicoll JA
    Acta Neuropathol; 2010 Jul; 120(1):13-20. PubMed ID: 20532897
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Aluminum modifies the properties of Alzheimer's disease PHF tau proteins in vivo and in vitro.
    Shin RW; Lee VM; Trojanowski JQ
    J Neurosci; 1994 Nov; 14(11 Pt 2):7221-33. PubMed ID: 7525898
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.